What is the appropriate evaluation and management for a patient with chronic headache who now has blurry vision and a headache pain intensity of 6/10?

Immediate Neuroimaging and Urgent Evaluation Required

This patient with chronic headache who now presents with new-onset blurry vision requires urgent evaluation to rule out secondary causes of headache, particularly those threatening vision and life. The combination of chronic headache with new visual symptoms represents a potential "red flag" that demands immediate action 1.

Critical First Steps: Rule Out Secondary Causes

Before attributing symptoms to primary headache disorders, you must exclude dangerous secondary causes through careful history and examination 1:

Red Flags Present in This Case:

• New visual symptoms (blurry vision) in a patient with chronic headache
• Change in headache pattern or associated symptoms

Urgent Conditions to Exclude:

Vision-threatening emergencies:

• Idiopathic intracranial hypertension (IIH) - presents with chronic headache and visual disturbances; papilledema can cause progressive vision loss 2
• Cerebral aneurysm - blurred vision with eye discomfort can precede oculomotor nerve palsy in warning headaches before rupture 3
• Acute angle-closure glaucoma - causes headache with blurred vision and eye pain
• Giant cell arteritis (if age >50) - can cause permanent vision loss

Other secondary causes:

• Intracranial mass or hemorrhage
• Meningitis/encephalitis
• Venous sinus thrombosis

Immediate Evaluation Protocol

History Details to Obtain:

• Onset of blurry vision: sudden vs gradual, unilateral vs bilateral
• Eye pain or discomfort: location, quality
• Headache characteristics: any change from baseline chronic pattern
• Associated symptoms: diplopia, ptosis, photophobia, nausea/vomiting
• Medication overuse: frequency of analgesic use (≥15 days/month suggests medication overuse headache) 4
• Age and risk factors: >50 years, hypertension, cardiovascular disease, immunosuppression 5

Physical Examination Essentials:

• Visual acuity testing - document any deficit
• Pupillary examination - check for afferent pupillary defect, anisocoria
• Fundoscopic examination - look for papilledema (IIH), hemorrhages
• Visual field testing - confrontation at minimum
• Extraocular movements - assess for nerve palsies
• Complete neurologic examination - focal deficits suggest structural lesion
• Temporal artery palpation (if age >50) - tenderness suggests arteritis

Immediate Diagnostic Testing:

If ANY of the following are present, obtain urgent neuroimaging (CT or MRI with vascular imaging):

• Abnormal neurologic examination
• Papilledema on fundoscopy
• Acute onset or significant change in headache pattern
• Age >50 with new headache features
• Progressive visual symptoms 1, 6

Additional urgent tests as indicated:

• Intraocular pressure measurement - if acute angle-closure suspected
• ESR/CRP - if age >50 and giant cell arteritis suspected
• Lumbar puncture with opening pressure - if IIH suspected and imaging excludes mass lesion 2

Management Based on Findings

If Secondary Cause Identified:

Treat the underlying condition urgently (neurosurgical consultation for aneurysm, ophthalmology for glaucoma, acetazolamide for IIH, etc.)

If No Secondary Cause Found (Primary Headache Disorder):

This likely represents chronic migraine (≥15 headache days/month for ≥3 months, with ≥8 days meeting migraine criteria) 1.

Acute Treatment for Current Episode (Pain 6/10):

First-line approach 4:

1. NSAID (ibuprofen 400-800 mg or naproxen sodium 550 mg) PLUS
2. Antiemetic if nausea present (metoclopramide 10 mg or prochlorperazine 25 mg)

If inadequate response to NSAIDs alone:

• Add triptan (sumatriptan 50-100 mg, rizatriptan 10 mg, or zolmitriptan 2.5-5 mg) to the NSAID 4
• Combination therapy (triptan + NSAID) is more effective than either alone

Alternative acute options if triptans contraindicated/ineffective:

• CGRP antagonists (gepants): rimegepant 75 mg or ubrogepant 50-100 mg 4, 7
• Avoid opioids and butalbital - these cause medication overuse headache and dependency 4

Preventive Therapy (Essential for Chronic Migraine):

Every patient with chronic migraine requires preventive therapy 1. Initiate immediately:

First-line preventive options 8:

• Topiramate 25-100 mg daily (only preventive proven effective in chronic migraine trials) 1
• Beta-blockers: propranolol 80-240 mg, metoprolol 100-200 mg, or atenolol 50-100 mg daily
• Candesartan 16 mg daily

Second-line options 8:

• Amitriptyline 25-150 mg at bedtime
• Flunarizine (if available)

Third-line/specialist options:

• CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) 8, 7
• OnabotulinumtoxinA (Botox) - FDA-approved specifically for chronic migraine prophylaxis 1

Address Medication Overuse:

If patient uses acute medications ≥10 days/month (triptans/opioids) or ≥15 days/month (NSAIDs/acetaminophen), medication overuse headache is likely contributing 4. Limit acute treatment to <2 days per week while optimizing preventive therapy 9.

Critical Pitfalls to Avoid

1. Never assume chronic headache with new visual symptoms is "just migraine" - always exclude secondary causes first
2. Do not miss papilledema - perform fundoscopy on every patient with chronic headache and visual symptoms
3. Do not overlook giant cell arteritis in patients >50 - permanent vision loss can occur within hours
4. Do not prescribe opioids or butalbital for chronic headache - these worsen the condition 4
5. Do not forget that blurred vision with eye discomfort can herald aneurysm rupture 3

Disposition

• Urgent ophthalmology referral if any visual deficit, papilledema, or elevated intraocular pressure
• Neurology/headache specialist referral for chronic migraine management and consideration of advanced therapies 1
• Emergency department if any concern for aneurysm, stroke, or other life-threatening cause